European Atherosclerosis Society Consensus Panel on statin-associated muscle symptoms

(3:28)

EAS Clinician's Handbook: Dyslipidaemia and Atherosclerosis Prevention, Diagnosis and Treatment

(2:24)

Is too much exercise raising our risk of heart disease?

(52)

FHSC, a global registry of over 61,000 with this inherited high cholesterol disorder, reports at ESC

(1:46)

The genetic burden in CVD, Prof. H. Schunkert quick summary from EAS 2019

(5:21)

Francois Mach, Switzerland, talks about the new ESC/EAS guidelines on management of dyslipidaemias

(7:)

Prof. Tokgözoğlu summarises the approach of high- and very high risk patients in the new guidelines

(5:55)

Michal Vrablik, Czech Republic, on the new ESC/EAS guidelines on management of dyslipidaemias

(1:57)

Cardiorenal Collaboration: Optimizing Multidisciplinary Care in the CvRM Patient

(16:)

Prof. S. Nicholls: patient progress despite very low LDL cholesterol levels on a PCSK9 inhibitor

(1:12)

New ESC/EAS Dyslipidaemia Guidelines out now - what is new?

(22:15)

LDL Causality - EAS consensus paper

(1:38)

What is Atherosclerosis?

(1:5)

Prof. Margus Viigimaa, Estonia, on the new ESC/EAS guidelines on management of dyslipidaemias

(2:25)

Prof. Ulf Landmesser, Germany, on the new guidelines on management of dyslipidaemias

(2:10)

85th European Atherosclerosis Society Congress - 25 April 2017

(3:9)

Preventing cvd risk: Where do we stand? Quick Summary by Chris Packard at EAS Congress 2019

(6:3)

ApoB Is A Direct Cause Of Atherosclerosis - Lower It To STOP CVD (Peter Attia)

(56)